Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine with or without Esketamine PCIA after Laparoscopic Cholecystectomy
ChiCTR2400088373Phase 4Recruiting
- Sponsor
- Fuyang Women and Children's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine and esketamine in postoperative pain (3 arms), sponsored by Fuyang Women and Children's Hospital. Primary endpoints: VAS pain score and Total and effective compression times of analgesic pump. Started Aug 2024; status: recruiting.
02
Drugs
nalbuphineesketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400088373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088373.